• U-M stem cell trial to enter crucial phase

The Detroit News by Kim Kozlowski, March 15, 2011

The first clinical trial using stem cells in Lou Gehrig's disease patients soon will begin testing the safety of the procedure in an area of the spine that eventually could be life-saving.

The landmark trial aims to slow progression of the fatal disease, also known as amyotrophic lateral sclerosis, or ALS, by injecting millions of stem cells into patients.

Select media coverage in this website is provided for the information and convenience of the public, and is not intended to be all-encompassing nor an endorsement of the specific stories or media outlets.

Privacy and Terms ©Neuralstem, Inc. 2014